Cian Healthcare Ltd (542678)
Latest quarterly results (Q4 FY26)
In its latest reported quarter, Q4 FY26, Cian Healthcare's revenue was ₹17.0 Cr (+41.7% year on year), and net profit ₹-18.0 Cr (a bigger loss than a year earlier); the operating margin was -17.6%.
| Q4 FY26 (₹ Cr) | Value | YoY vs Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue | ₹17.0 | +41.7% | — |
| Operating profit | ₹-3.0 | loss narrowed | — |
| Net profit | ₹-18.0 | loss widened | — |
| EPS (₹) | -7.19 | loss widened | — |
| Operating margin | -17.6% | — | — |
📢 Recent Corporate Announcements
Cian Healthcare Ltd has announced the resignation of its statutory auditor, M/s. S S R C A & Co., effective August 27, 2026. The auditor was appointed on January 10, 2025, and their tenure was originally scheduled to run through January 09, 2029. The auditor cited professional commitments and pre-occupations, confirming no other material reasons or unresolved concerns. The company will place the Audit Committee views on record and initiate the process to appoint a replacement.
- Statutory auditor M/s. S S R C A & Co. resigned effective August 27, 2026.
- Auditor tenure was cut short prior to the scheduled expiration on January 09, 2029.
- Last submitted report was for the financial year ended March 31, 2026.
- Auditor stated resignation was due to professional preoccupations with no material audit concerns raised.
BSE Limited has revised the trading market lot size for Cian Healthcare Ltd from 2,000 equity shares to 137 equity shares, effective August 24, 2026. The revision follows the ratio outlined in the NCLT Order dated December 18, 2025, which approved the Resolution Plan submitted by Successful Resolution Applicant Mr. Pradeep Kumar Jain. Trading approval was previously granted for 2,50,00,000 fully paid-up equity shares on March 30, 2026. This administrative adjustment reduces the minimum transaction ticket size for investors on the exchange.
- Market lot size reduced from 2,000 shares to 137 fully paid-up equity shares
- Effective date for revised lot size is Monday, August 24, 2026
- Pertains to trading approval of 2,50,00,000 fully paid-up equity shares
- Adjustment executed pursuant to Hon'ble NCLT Order dated December 18, 2025
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
